-
Regenexx celebrates 15 years, performed 90K+ procedures — 5 things to know
This year marks the 15th anniversary of orthobiologic physician group Regenexx. -
Onkos Surgical launches bone scaffold for orthopedic revision surgeries, tumors
Onkos Surgical on Feb. 6 launched GenVie Magnesium Bone Scaffold, a magnesium-based bone void filler for orthopedic conditions. -
'The most expensive drug in the world' — 10 details on Novartis' $2.1M drug for spinal muscular atrophy
Zolgensma, a gene therapy drug for spinal muscular atrophy, has been on the market since June 2019 and is widely reported to be the most expensive drug in the world. -
Dr. Steven Cyr offering spinal stem cell treatments at Texas clinic
Steven Cyr, MD, is now providing stem cell treatments at SASpine in San Antonio. -
Cleveland Clinic to test new drug for early detection of multiple sclerosis
Myeliviz, a new drug to help diagnose multiple sclerosis in its earlier stages was recently approved by the FDA for human clinical trials. -
$186M in Q4 sales delivered by Novartis gene therapy for spinal muscular atrophy
Zolgensma, Novartis' gene therapy drug for spinal muscular atrophy, totaled $186 million in fourth quarter sales, according to Stat. -
The spinal fusion market: 8 key points
Here are eight things to know about the spinal fusion market. -
Dr. Ryan Woods to offer regenerative medicine at Wisconsin orthopedic center
In February, Ryan Woods, MD, will provide regenerative medicine services to patients at Orthopedics & Sports Medicine BayCare Clinic in Manitowoc, Wis., according to the Herald Times Reporter. -
HSS orthopedic surgeon joins NanoFUSE Biologics' growing scientific advisory board
NanoFUSE Biologics appointed Answorth Allen, MD, Jan. 16 to its scientific advisory board, reports Benzinga. -
4 developments in spine and orthopedics biologics
The potential of spine-targeted biologics is immense and quickly developing. Here are four recent stories on notable developments or recognitions: -
Dr. Mohamad Khazaei recognized for stem cell research on spinal cord injuries
Stem Cells Translational Medicine recently awarded Mohamad Khazaei, PhD, its Young Investigator Award for his research on cell-based treatments for spinal cord injuries, reports News Medical Life Sciences. -
Bone Biologics product promotes bone growth — 4 insights
Orthobiologic developer Bone Biologics said its rhNELL-1 product promoted bone formation in advanced spine models. -
Humans have a 'cellular clock' that controls spine growth, researchers confirm
Developmental biologist Olivier Pourquié, PhD, identified a cellular segmentation clock-like mechanism in humans that controls spine development, The Harvard Gazette reports. -
Ortho-biologics company launches cellular bone allograft
Ortho-biologics company Royal Biologics launched Magnus, a DMSO-free viable cellular bone allograft, the first of its kind to be DMSO-free. -
Dr. Darren Lebl joins NanoFUSE Biologics scientific advisory board: 4 things to know
NanoFUSE Biologics named Darren Lebl, MD, to its scientific advisory board. -
Bioventus, BCBS of Michigan partner in knee OA initiative — 3 things to know
Bioventus is partnering with Blue Cross Blue Shield of Michigan to provide its knee osteoarthritis treatments to Medicare Advantage and Commercial patients, beginning Jan. 1, 2020. -
9 big developments in stem cell research for spine in 2019
Here are nine key developments in stem cell research for spine this year: -
$2.1M spinal muscular atrophy drug administered to 1-year-old girl at Michigan hospital
Grand Rapids, Mich.-based Helen DeVos Children's Hospital provided a $2.1 million gene therapy drug for spinal muscular atrophy to a one-year-old girl in November, reports Fox 47 News. -
Irish researcher awarded $2.2M grant for project to study spinal regeneration
Dr. Conor Buckley, director of biomedical engineering at Trinity College Dublin in Ireland, received a European Research Grant to study spinal regeneration on Dec. 10, reports The Irish Times. -
Anika launches new regenerative therapy for bone repair procedures
Anika launched Tactoset, its new surgical therapy for bone repair procedures at the Orthopaedic Summit 2019: Evolving Techniques, which is taking place in Las Vegas, Dec. 11-14.
Page 14 of 34